Smith Group Asset Management’s Varian Medical Systems, Inc. VAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,500
Closed -$359K 393
2020
Q1
$359K Sell
3,500
-173,757
-98% -$22.9M 0.02% 135
2019
Q4
$25.2M Sell
177,257
-19,221
-10% -$2.45M 1.06% 32
2019
Q3
$23.4M Sell
196,478
-74,108
-27% -$8.82M 0.82% 50
2019
Q2
$36.8M Buy
270,586
+42,537
+19% +$5.68M 1.24% 21
2019
Q1
$32.3M Sell
228,049
-5,306
-2% -$697K 1.05% 35
2018
Q4
$26.5M Sell
233,355
-4,890
-2% -$559K 0.94% 39
2018
Q3
$26.6M Sell
238,245
-9,383
-4% -$1.06M 0.76% 53
2018
Q2
$28.2M Buy
247,628
+16,376
+7% +$1.96M 0.82% 46
2018
Q1
$28.3M Sell
231,252
-1,725
-0.7% -$206K 0.93% 32
2017
Q4
$25.9M Buy
232,977
+6,209
+3% +$667K 0.81% 44
2017
Q3
$26.6M Sell
226,768
-22,926
-9% -$2.35M 0.89% 37
2017
Q2
$25.8M Buy
+249,694
New +$24M 0.79% 48
2016
Q1
Sell
-15,194
Closed -$1.08M 538
2015
Q4
$1.08M Buy
+15,194
New +$1.05M 0.03% 169

Other funds holding VAR

Smith Group Asset Management's VAR Position: Q2 2020 in Review

Smith Group Asset Management sold out of Varian Medical Systems, Inc. (VAR) in Q2 2020, closing a stake of 3,500 shares — an estimated $359K sold.

Smith Group Asset Management first reported a position in VAR in Q4 2015 and held it in 13 quarters. The position peaked at $36.8M in Q2 2019. 575 funds tracked by Wall St. Rank hold VAR as of Q2 2020.

  • Smith Group Asset Management reported no remaining Varian Medical Systems, Inc. position as of Q2 2020 after selling out during the quarter.
  • Smith Group Asset Management sold 3,500 Varian Medical Systems, Inc. shares in Q2 2020, an estimated $359K.
  • Smith Group Asset Management first reported a position in Varian Medical Systems, Inc. in Q4 2015 and held it in 13 quarters.
  • Smith Group Asset Management's Varian Medical Systems, Inc. position peaked at $36.8M in Q2 2019.
  • 575 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q2 2020.

Based on Smith Group Asset Management's 13F filing for Q2 2020, filed 6 Aug 2020.